Cargando…
Transcellular Model for Neutral and Charged Nanoparticles Across an In Vitro Blood–Brain Barrier
PURPOSE: The therapeutic drug-loaded nanoparticles (NPs, 20–100 nm) have been widely used to treat brain disorders. To improve systemic brain delivery efficacy of these NPs, it is necessary to quantify their transport parameters across the blood–brain barrier (BBB) and understand the underlying tran...
Autores principales: | Zhang, Lin, Fan, Jie, Li, Guanglei, Yin, Zhaokai, Fu, Bingmei M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592456/ https://www.ncbi.nlm.nih.gov/pubmed/33113565 http://dx.doi.org/10.1007/s13239-020-00496-6 |
Ejemplares similares
-
ACKR1 favors transcellular over paracellular T‐cell diapedesis across the blood‐brain barrier in neuroinflammation in vitro
por: Marchetti, Luca, et al.
Publicado: (2021) -
Transcellular blood–brain barrier disruption in malaria-induced reversible brain edema
por: Jin, Jessica, et al.
Publicado: (2022) -
Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF
por: Dohgu, Shinya, et al.
Publicado: (2011) -
Transcellular Targeting of Fiber- and Hexon-Modified Adenovirus Vectors across the Brain Microvascular Endothelial Cells In Vitro
por: Laakkonen, Johanna P., et al.
Publicado: (2012) -
Endothelial β-Catenin Deficiency Causes Blood-Brain Barrier Breakdown via Enhancing the Paracellular and Transcellular Permeability
por: Hussain, Basharat, et al.
Publicado: (2022)